Annual Meeting 2023 | Panel 8

Podcast & Video,
Mitigating Risk in Life Sciences Licensing Transactions

Peter Rosenbaum, Jenner
Art Cohn, DLA Piper, Of Counsel
Connie Matteo, Pfizer, Assistant General Counsel

This panel examined the provisions in a typical life sciences licensing transaction to clarify the purpose and considerations for deploying the provisions in an effort to optimize the value of the transaction and avoid disputes - all as set forth in a new book of the same title, that has been published by CPR and its Healthcare & Life Sciences Committee. The concepts can be applied to many other collaborative transactions.